SCHEMBL3378744

SCHEMBL3378744

Clc1ccc(Sc2ccccc2)nc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.53
HTT P42858 2/20 0.48
HPGD P15428 2/20 0.48
CYP11B1 P15538 1/20 0.45
CYP11B2 P19099 1/20 0.45
ALDH1A1 P00352 3/20 0.42
KDM4E B2RXH2 2/20 0.42
CYP1A2 P05177 2/20 0.42
CYP2C9 P11712 2/20 0.42
CYP2C19 P33261 2/20 0.42
LMNA P02545 2/20 0.41
ATM Q13315 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
CHRNA7 P36544 1/20 0.41
GAA P10253 2/20 0.40
HAO1 Q9UJM8 1/20 0.40
TP53 P04637 1/20 0.40
MAPT P10636 1/20 0.40
GRM5 P41594 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28456854 0.84 L3MBTL1 (0.42) L3MBTL1ALDH1A1KDM4ELMNAHAO1
SCHEMBL11139134 0.83 KMT2A (0.49) L3MBTL1HTTHPGDCYP11B1CYP11B2
SCHEMBL10834017 0.81 HPGD (0.50) L3MBTL1HTTHPGDCYP11B1CYP11B2
SCHEMBL20379720 0.80 MAPT (0.51) L3MBTL1HPGDALDH1A1KDM4ECYP1A2
SCHEMBL510066 0.78 HTT (0.47) L3MBTL1HTTHPGDCYP11B1CYP11B2
SCHEMBL8866408 0.78 HPGD (0.47) L3MBTL1HTTHPGDCYP11B1CYP11B2
SCHEMBL8736890 0.78 CYP11B1 (0.55) L3MBTL1HTTHPGDCYP11B1CYP11B2
SCHEMBL31013394 0.78 HTT (0.47) L3MBTL1HTTHPGDCYP11B1CYP11B2
SCHEMBL11369506 0.78 HPGD (0.52) L3MBTL1HTTHPGDCYP11B1CYP11B2
SCHEMBL10483934 0.77 CYP11B1 (0.55) L3MBTL1HTTHPGDCYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1476428-B1 PYRIDYL SULFONE DERIVATIVES AS 5-HT6 RECEPTOR LIGANDS PHARMACIA & UPJOHN CO LLC (US) 2010-11-17 EP disclosed
US-6855709-B2 Pyridyl sulfone derivatives PHARMACIA & UPJOHN COMPANY (US) 2005-02-15 US disclosed
EP-1476428-A1 PYRIDYL SULFONE DERIVATIVES AS 5-HT6 RECEPTOR LIGANDS PHARMACIA & UPJOHN COMPANY (US) 2004-11-17 EP disclosed
US-20030186968-A1 Pyridyl sulfone derivatives PHARMACIA & UPJOHN COMPANY 2003-10-02 US disclosed
WO-2003072548-A1 PYRIDYL SULFONE DERIVATIVES AS 5-HT RECEPTOR ANTAGONISTS PHARMACIA & UPJOHN COMPANY (US) 2003-09-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030186968-A1 Pyridyl sulfone derivatives HTR6, TPH1, HTR1A L3MBTL1 3129/4885HTT 1000/4885HPGD 715/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.